AdaptHealth outlines path to 20% margin on largest capitated contract by Q4 next year while raising 2026 adjusted EBITDA

AdaptHealth Q3 2026 earnings: raised revenue and EBITDA guidance, contract margins improved, but cash flow and Medline risks remain.